{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:43:30Z","timestamp":1760060610418,"version":"build-2065373602"},"reference-count":39,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CONACYT","award":["CB-132353","2015\/0322\/0944\/0946"],"award-info":[{"award-number":["CB-132353","2015\/0322\/0944\/0946"]}]},{"name":"PIFI-SIP-COFAA\/IPN","award":["CB-132353","2015\/0322\/0944\/0946"],"award-info":[{"award-number":["CB-132353","2015\/0322\/0944\/0946"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>Histone deacetylase inhibitors (HDACis) induce the expression of multidrug resistance (MDR) pumps and can even display the MDR phenotype in cell lines. This is the first report to include the profiles of ATP-binding cassette (ABC) transporters in intrinsically expressed HeLa cells as well as those acquired due to a 5 mM valproic acid (VPA) treatment. Expression of ABC transporters related to the MDR phenotype was analyzed by RT-PCR in untreated HeLa cells and HeLa cells treated with 5 mM VPA. The ABCB5 protein was identified in HeLa cells by immunocytochemistry. HeLa cell treatment with 5 mM VPA increased ABCB1 expression and triggered the de novo expression of ABCB5 in mRNA and protein. Despite the expression of ABCB5 and the overexpression of ABCB1, VPA reduced the growth rate by 20%, delayed doubling time by 25%, and decreased the number of living cells per well to 50% after 72 h. Pretreatment with VPA for 24 h followed by cotreatment with doxorubicin (DOX) sensitized HeLa cells to DOX. However, for the de novo expression of ABCB5, HeLa cells did not acquire the MDR phenotype from the 5 mM VPA treatment. The ABCB5 isoform induced by VPA treatment probably lacks MDR activity.<\/jats:p>","DOI":"10.3390\/cimb47090749","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T15:10:46Z","timestamp":1757603446000},"page":"749","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Valproic Acid as a Histone Deacetylase Inhibitor Induces ABCB1 Overexpression and De Novo ABCB5 Expression in HeLa Cells"],"prefix":"10.3390","volume":"47","author":[{"given":"Gabriela Rebeca","family":"Luna-Palencia","sequence":"first","affiliation":[{"name":"Departamento de Biotecnolog\u00eda y Bioingenier\u00eda, Centro de Investigaci\u00f3n y de Estudios Avanzados del Instituto Polit\u00e9cnico Nacional, Mexico City 07360, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Correa-Basurto","sequence":"additional","affiliation":[{"name":"Laboratorio de Dise\u00f1o y Desarrollo de Nuevos F\u00e1rmacos e Innovaci\u00f3n Biotecnol\u00f3gica, Escuela Superior de Medicina del IPN, Mexico City 11340, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismael","family":"V\u00e1squez-Moctezuma","sequence":"additional","affiliation":[{"name":"Laboratorio de Morfolog\u00eda, Escuela Superior de Medicina del IPN, Mexico City 11340, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/0005-2736(73)90191-0","article-title":"Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells","volume":"323","author":"Dano","year":"1973","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_3","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: An overview","volume":"55","author":"Schinkel","year":"2003","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Moitra, K., Scally, M., McGee, K., Lancaster, G., Gold, B., and Dean, M. (2011). Molecular Evolutionary Analysis of ABCB5: The Ancestral Gene Is a Full Transporter with Potentially Deleterious Single Nucleotide Polymorphims. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016318"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0006-291X(02)02658-X","article-title":"ABCC13, an unusual truncated ABC transporter, is highly expressed in fetal human liver","volume":"299","author":"Yabuuchi","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.trecan.2022.07.001","article-title":"Deciphering the roles of ABCB5 in normal and cancer cells","volume":"8","author":"Duvivier","year":"2022","journal-title":"Trends Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"100743","DOI":"10.1016\/j.drup.2021.100743","article-title":"Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance","volume":"54","author":"Wang","year":"2021","journal-title":"Drug Resist. Updates"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1535-7511.2005.05311.x","article-title":"How to explain multidrug resistance in epilepsy?","volume":"5","year":"2005","journal-title":"Epilepsy Curr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-11-0221","article-title":"ABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patients","volume":"71","author":"Wilson","year":"2011","journal-title":"Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"D\u00edaz-Anaya, A.M., Gerard, L., Albert, M., Gaussin, J.F., Boonen, M., and Gillet, J.P. (2023). The \u03b2 Isoform of Human ATP-Binding Cassette B5 Transporter, ABCB5\u03b2, Localizes to the Endoplasmic Reticulum. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242115847"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.jid.2019.01.036","article-title":"Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Capacities","volume":"139","author":"Sana","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3892\/ol.2021.12827","article-title":"Effect of melanoma stem cells on melanoma metastasis","volume":"22","author":"Yin","year":"2021","journal-title":"Oncol. Lett."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1158\/0008-5472.CAN-04-3327","article-title":"ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma","volume":"65","author":"Frank","year":"2005","journal-title":"Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3727\/096504016X14734149559061","article-title":"ABCB5-ZEB1 Axis Promotes Invasion and Metastasis in Breast Cancer Cells","volume":"5","author":"Yao","year":"2017","journal-title":"Oncol. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2015.10.010","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade","volume":"370","author":"Chen","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1158\/1078-0432.CCR-07-2114","article-title":"Mechanisms of resistance to histone deacetylase inhibitors and their therapeutic implications","volume":"13","author":"Fantin","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Emran, T.B., Shahriar, A., Mahmud, A.R., Rahman, T., Abir, M.H., Siddiquee, M.F., Ahmed, H., Rahman, N., Nainu, F., and Wahyudin, E. (2022). Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.891652"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.20892\/j.issn.2095-3941.2019.0284","article-title":"ABC transporters and the hallmarks of cancer: Roles in cancer aggressiveness beyond multidrug resistance","volume":"17","author":"Muriithi","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Minucci","year":"2001","journal-title":"EMBO J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/BJ20070779","article-title":"Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors","volume":"409","author":"Khan","year":"2008","journal-title":"Biochem. J."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Adhikari, S., Bhattacharya, A., Adhikary, S., Singh, V., Gadad, S.S., Roy, S., and Das, C. (2022). The paradigm of drug resistance in cancer: An epigenetic perspective. Biosci. Rep., 42.","DOI":"10.1042\/BSR20211812"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"984","DOI":"10.2174\/1871520614666140127113218","article-title":"Three amino acid derivatives of valproic acid: Design, synthesis, theoretical and experimental evaluation as anticancer agents","volume":"14","year":"2014","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"ref_25","unstructured":"Roth, V. (2025, February 03). 2006 Doubling Time Computing. Available online: https:\/\/www.doubling-time.com\/compute.php."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/sj.bjp.0706830","article-title":"The antiepileptic and anticancer agent, valproic acid, induces P-glycoprotein in human tumour cell lines and in rat liver","volume":"149","author":"Eyal","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7896","DOI":"10.1158\/1078-0432.CCR-04-0795","article-title":"Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias","volume":"10","author":"Benderra","year":"2004","journal-title":"Clin. Cancer. Res."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Boyer, T., Gonzales, F., Barth\u00e9l\u00e9my, A., Marceau-Renaut, A., Peyrouze, P., Guihard, S., Lepelley, P., Plesa, A., Nibourel, O., and Delattre, C. (2019). Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive Study. Cancers, 11.","DOI":"10.3390\/cancers11091323"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Sucha, S., Sorf, A., Svoren, M., Vagiannis, D., Ahmed, F., Visek, B., and Ceckova, M. (2022). ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia. Biomed. Pharmacother., 150.","DOI":"10.1016\/j.biopha.2022.112962"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Chartrain, M., Riond, J., Stennevin, A., Vandenberghe, I., Gomes, B., Lamant, L., Meyer, N., Gairin, J.E., Guilbaud, N., and Annereau, J.P. (2012). Melanoma chemotherapy leads to the selection of ABCB5-expressing cells. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0036762"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/aps.2013.27","article-title":"Understanding and targeting cancer stem cells: Therapeutic implications and challenges","volume":"34","author":"Chen","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Gerard, L., Duvivier, L., Fourrez, M., Salazar, P., Sprimont, L., Xia, D., Ambudkar, S.V., Gottesman, M.M., and Gillet, J.P. (2024). Identification of two novel heterodimeric ABC transporters in melanoma: ABCB5\u03b2\/B6 and ABCB5\u03b2\/B9. J. Biol. Chem., 300.","DOI":"10.1016\/j.jbc.2023.105594"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2174\/1874467213666200730113828","article-title":"Epigenetic Evaluation of N-(2-hydroxyphenyl)-2-Propylpentanamide, a Valproic Acid Aryl Derivative with Activity Against HeLa Cells","volume":"14","year":"2021","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_34","first-page":"7291","article-title":"Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA","volume":"63","author":"Kim","year":"2003","journal-title":"Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Arce, C., P\u00e9rez-Plasencia, C., Gonz\u00e1lez-Fierro, A., de la Cruz-Hern\u00e1ndez, E., Revilla-V\u00e1zquez, A., Ch\u00e1vez-Blanco, A., Trejo-Becerril, C., P\u00e9rez-C\u00e1rdenas, E., Taja-Chayeb, L., and Bargallo, E. (2006). A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer. PLoS ONE, 1.","DOI":"10.1371\/journal.pone.0000098"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s11523-015-0370-0","article-title":"The Histone Deacetylase Inhibitor Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in Gemcitabine-Resistant Pancreatic Cancer Cells Possibly Through Inhibition of the DNA Repair Protein Gamma-H2AX","volume":"10","author":"Wang","year":"2015","journal-title":"Target Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.3892\/or.2015.3879","article-title":"HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells","volume":"33","author":"Ji","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Li, H., Zhang, Z., Gao, C., Wu, S., Duan, Q., Wu, H., Wang, C., Shen, Q., and Yin, T. (2019). Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3\/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells. Cell Biosci., 9, Erratum in Cell Biosci. 2023, 13, 206.","DOI":"10.1186\/s13578-019-0312-0"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.molmed.2022.11.001","article-title":"ABC transporters: Human disease and pharmacotherapeutic potential","volume":"29","author":"Moore","year":"2023","journal-title":"Trends Mol. Med."}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/47\/9\/749\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:44:00Z","timestamp":1760035440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/47\/9\/749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cimb47090749"],"URL":"https:\/\/doi.org\/10.3390\/cimb47090749","relation":{},"ISSN":["1467-3045"],"issn-type":[{"type":"electronic","value":"1467-3045"}],"subject":[],"published":{"date-parts":[[2025,9,11]]}}}